Immunosenescence: limitations of natural killer cell-based cancer immunotherapy.

导出 OA

翻译打印收藏纠错

第一作者： Raquel,Tarazona

第一单位： Immunology Unit, University of Extremadura, Cáceres, Spain.

作者： Raquel,Tarazona ^[1] ; Beatriz,Sanchez-Correa ^[1] ; Ignacio,Casas-Avilés ^[2] ; Carmen,Campos ^[3] ; Alejandra,Pera ^[4] ; Sara,Morgado ^[1] ; Nelson,López-Sejas ^[3] ; Fakhri,Hassouneh ^[3] ; Juan M,Bergua ^[2] ; Maria Jose,Arcos ^[2] ; Helena,Bañas ^[2] ; Javier G,Casado ^[5] ; Esther,Durán ^[6] ; Fernando,Labella ^[3] ; Rafael,Solana ^[7]

作者单位： Immunology Unit, University of Extremadura, Cáceres, Spain. ^[1] Department of Haematology, Hospital San Pedro de Alcantara, Cáceres, Spain. ^[2] IMIBIC - Reina Sofia University Hospital - University of Cordoba, REIPI, Córdoba, Spain. ^[3] IMIBIC - Reina Sofia University Hospital - University of Cordoba, REIPI, Córdoba, Spain.;Brighton and Sussex Medical School, University of Sussex, Brighton, UK. ^[4] Immunology Unit, University of Extremadura, Cáceres, Spain.;Stem Cell Therapy Unit, Minimally Invasive Surgery Centre Jesus Uson, Cáceres, Spain. ^[5] Histology and Pathology Unit, Faculty of Veterinary, University of Extremadura, Cáceres, Spain. ^[6] IMIBIC - Reina Sofia University Hospital - University of Cordoba, REIPI, Córdoba, Spain. rsolana@uco.es.;Department of Immunology, Facultad de Medicina Universidad de Córdoba, Avenida de Menéndez Pidal s/n, 14004, Córdoba, Spain. rsolana@uco.es. ^[7]

关键词 Ageing Cancer immunotherapy Checkpoint blockade NK cell immunosenescence PIVAC 15

主题词动物(Animals);人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive);杀伤细胞, 天然(Killer Cells, Natural);配体(Ligands);肿瘤(Neoplasms)

DOI 10.1007/s00262-016-1882-x

PMID 27530271

发布时间 2024-04-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交